SciELO - Scientific Electronic Library Online

vol.33 issue2Profound molecular response with ponatinib in chronic phase of chronic myeloid leukemia with resistance to imatinib and dasatinib: Case report and review of the literatureChronic venous insufficiency in the elderly author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Medica Herediana

Print version ISSN 1018-130XOn-line version ISSN 1729-214X


ZACARIAS-MENDOZA, Nathalie Victoria; COTERA-RAMON, Angela Ibeth  and  SALAZAR CACERES, Pedro Martín. Acute myocardial infarction in a patient with low cardiovascular risk and elevated lipoprotein (a). Case report. Rev Med Hered [online]. 2022, vol.33, n.2, pp.139-144.  Epub July 06, 2022. ISSN 1018-130X.

Lipoprotein(a) (Lp (a)) is a plasmatic lipid protein complex, which represents a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, conventional lipid assays are unable to measure or estimate Lp (a) and there are no specific therapies approved to substantially reduce Lp (a) concentrations. We report the case of a 49-year-old man with low cardiovascular risk who developed an acute myocardial infarction with ST elevation probably due to elevation of Lp (a) is reported. The purpose of this case report is to highlight the detection and analysis of Lp (a) in the assessment of cardiovascular risk. In addition, current and emerging therapies are described in patients with elevated Lp (a).

Keywords : Lipoprotein(a); Heart Disease Risk Factors; Myocardial Infarction; Acute Coronary Syndrome.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )